Hepatitis C infection in the general population of Iran: A systematic review

Hepatitis Monthly

Volumn 9, Issue 3, 2009, Pages 211-223

  Alavian, Seyed Moayed ^a   Ahmadzad Asl, Masoud ^b   Lankarani, Kamran Bagheri ^c   Shahbabaie, Mohammad Ali ^b   Ahmadi, Amir Bahrami ^b   Kabir, Ali ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Nikan Health Researchers Institute   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Hepatitis C; Iran; Prevalence

Indexed keywords

DATA ANALYSIS; DATA COLLECTION METHOD; EVIDENCE BASED PRACTICE; HEALTH PROGRAM; HEPATITIS C; HUMAN; IRAN; PREVALENCE; REVIEW; SAMPLING; SYSTEMATIC REVIEW;

EID: 70350751561     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (223)

1. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74 ( Pt 11):2391-2399 (Pubitemid 23332300)
2. Rezvan H, Ahmadi J, Farhadi M. A preliminary study on the prevalence of anti-HCV amongst healthy blood donors in Iran. . Vox Sang. 1994;67(Suppl.2):A 100.
3. Mansour-Ghanaei F, Fallah M, Jafarshad R, Joukar F, Pourtahmasbi A, Bahari-Moghaddam A. Seroprevalence of Hepatitis B and C among Residents of Guilan Nursing Home. Hepat Mon. 2007;7(3):139-1141.
4. Javadzadeh-Shahshahani H. [Comparison of the positive predicative value of two enzyme immunoassay screening kits for hepatitis C in blood donors]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2007;4(1):51-57
5. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007;13(2):156-163 (Pubitemid 46237947)
6. Metanat M, Sharifi-Mood B, Sane'i-Moghaddam E, Alavi-Na'ini R, Naderi M, Khosravi S. [Prevalence of hepatitis C among diabetes mellitus patients in Zahedan]. Tabibe Shargh Res J. 2006;8(3):179-186
7. Kedda MA, Kew MC, Coppin A. Hepatocarcinogenic potential of genotype 5 of hepatitis C virus. Trop Gastroenterol. 1997;18(4):153-155
8. Brown RS, Jr., Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003;9(11):S10-3.
9. Tillmann HL, Manns MP. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci. 1996;41(12 Suppl):27S-40S.
10. Van der Poel CL, Cuypers HT, Reesink HW, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991;337(8737):317-319
11. Gao Q, Liu D, Zhang S, Tong L. [Analyses of anti-hCV detected by ELISA and HCV RNA detected by RT-nPCR in chronic hepatitis C virus infectors]. Wei Sheng Yan Jiu. 2007;36(1):69-71.
12. Sharifi V, Yousefi-Nooraie R, Rahimi-Movaqar A, Mesgarpour B, Basirnia A. Development of a quality assessment tool for prevalence studies in mental health [unpublished work].
13. Tajbakhsh E, Ya'ghoobi R, Vahedi AR. [A serological survey on hepatitis C virus antibody in blood donors with an ELISA method]. Tehran Univ Med J. 2007;65(8):69-73.
14. Bozorghi SH, Ramezany H, Vahid T, et al. [Assessment of prevalence and risk factors of hepatitis C virus infection in haemodialysis patients in Ghazvin]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):331-337
15. Zandieh T, Cohan N, Samiei S, Amini S, Ataei Z, Kavari M. Characteristics and prevalence of occult hepatitis B virus infection in patients with hepatitis C in Iran. Med J Islamic Republic of Iran. 2005;19(2):147-151 (Pubitemid 46094946)
16. Ahmadi Pour MH, Keivani H, Sabahi F, Alavian SM. Determination of HCV genotypes, in Iran by PCR-RFLP. Iranian J Publ Health. 2006;35(4):54-61. (Pubitemid 46178740)
17. Sarveghad MR, Bojdi A, Farrokhnia M, Javanian M. [Epidemiologic study of virus genotypes in chronic hepatitis C]. J Mashhad Sch Med. 2006;49(93):309-314
18. Shavakhi A, Esteghamat F, Sharifian A, et al. [Evaluation of hepatitis E in cirrhotic patients, a case control study]. Govaresh 2007;12(1):27-29
19. Ziaei M, Zarban A, Malekinejad P, Akhbari H. Evaluation of HGV viremia prevalence and its co-infection with HBV, HCV, HIV and HTLV-1 in hemophilic patients of Southern Khorassan, Iran. Hepat Mon. 2007;7(1):11-14
20. Sadeghipoor HR, Agah S, Pajang R, et al. [Frequency determination of pathological findings regarding Ishak system in patients with chronic hepatitis and cirrhosis admitted to Rasoul-e-Akram hospital between 1997 to 2002]. J Iran Univ Med Sci. 2006;13(50):93-98
21. Zahedi MJ, Darvish-Moghadam S. [Frequency of Hepatitis B and C infections among Hemophiliac patients in Kerman]. J Kerman Univ Med Sci. 2004;3(11):131-135
22. Delavari M, Tabataba'i SM. [Frequency of hepatitis C and its related factors in blood donors in Kerman in 2003]. Journal of Army Univ Med Sci Islamic Republic of Iran. 2004;2(2):353-357
23. Alavi S, Arzanian MT, Hatami K, Shirani A. [Frequency of hepatitis C in thalassemic patients and its association with liver enzymes, mofid hospital, Tehran, 2002]. Research in Medicine, J Shahid Beheshti Sch Med. 2005;29(3):213-217
24. Esma'ili MR, Mostafazadeh A, Sharbatdaran M, Hajiahmadi M, Alijanpoor M. Hepatitis C in blood products receivers. Iran J Pediatr. 2004;14(1):15-20.
25. Ghadir MR, Jafari E, Amiriani MT, Rezvan H, Amini S, Pourshams A. [Hepatitis C in Golestan Province, Iran]. Govaresh. 2006;11(3):158-162
26. Jabbari A, Besharat S, Khodabakhshi B. Hepatitis C in hemodialysis centers of Golestan province, northeast of Iran (2005). Hepat Mon. 2008;8(1):61-65 (Pubitemid 351802699)
27. Alavian SM, Hajariazdeh B, Malekzadeh R. [Hepatitis C in Hemophiliacs]. Govaresh. 2003;8(4):139-148
28. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-1097 (Pubitemid 35013965)
29. Akbari A, Imanieh MH, Karimi M, Tabataba'i HR. Hepatitis C virus antibody positive cases in multitransfused thalassemic patients in South of Iran. Hepat Mon. 2007;7(2):63-66
30. Hosseini Asl SK. High prevalence of HIV, HBV, HCV infection in gypsy population residing in Chaharmahal and Bakhtiari province. J Thromb Haemost. 2003;1:1.
31. Amini Kafi-Abad S, Talebian A, Ranjbar-Kermani F, Moghtada'i M, Sobhani M, Sami'i S. [Mini-pool screening for HCV infection in Iranian blood donors: Preliminary results]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;2(3):13-21.
32. Alavian SM. Networking for Overcoming on Viral Hepatitis in Middle East and Central Asia:"Asian Hepatitis Network". Hepat Mon. 2007;7(4):181-182
33. Saboor B, Boroomand P, Mehrabi Y, Ghanbari M, Zarrinfam H. [Prevalence and risk factors of hepatitis C infection in hemodialysis patients (Kermanshah ,1999-2000)]. Behbood, J Kermanshah Univ Med Sci. 2003;7(3):60-66
34. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iran Med. 2003;6(1):1-4. (Pubitemid 36748005)
35. Motlagh ME, Makvandi M, Jalali MT. [Prevalence of anti-HCV among pregnant women]. J Qazvin Univ Med Sci. 2001(18):59-63.
36. Rowhani-Rahbar A, Tabatabee-Yazdi A, Panahi M. Prevalence of common blood-borne infections among imprisoned injection drug users in Mashhad, North-East of Iran. Arch Iran Med. 2004;7(3):190-194 (Pubitemid 39468126)
37. Poorahmad M, Javady AA, Karimi I, Ata'i B, Kassa'ian N. Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran. Infect Dis Clin Pract. 2007;15(6):368-372 (Pubitemid 350147814)
38. Mohtasham-Amiri Z, Rezvani M, Ja'fari-Shakib R, Ja'fari-Shakib A. [Prevalence of HCV and high-risk behaviors in drug addiction inmates in Rasht, Iran]. Payesh. 2007;6(1):5-10.
39. Alavian SM, Kafaee J, Yektaparast B, et al. [Prevalence and risk factors for aquiring hepatitis C in hemodialysis patients in Gazvin (2001)]. J Qazvin Univ Med Sci. 2004;29:16-20.
40. Ziaei M, Namaei MH, Hosseini SM, Azarkar SG. [Prevalence of HCV infection and related viremia in hemophilic patients registered in Khorasan hemophilia society]. Ofogh-e-Danesh, J Gonabad Univ Med Sci. 2005;11(3):54-60.
41. Alavian S, M., Ardeshiri A, Hajarizadeh B. [Prevalence of HCV, HBV and HIV infections among Hemophiliacs]. Hakim Res J. 2003;2(6):45-51.
42. Sane'i-Moghaddam E, Savadkoohi S, Rakhshani F. [Prevalence of hepatitis B and C in patients with major Beta-thalassaemia referred to Ali-Asghar hospital In Zahedan, 2002]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2004;1(1):19-26.
43. Torabi SE, Abed-Ashtiani K, Dehkhoda R, et al. [Prevalence of Hepatitis B and C in Thalassemic patients of East Azarbaijan in 2003]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;2(4):115-123
44. Mansour-Ghanaei F, Fallah MS, Ja'farshad R, et al. [Prevalence of hepatitis B and hepatitis C, and their risk factors among Guilan blood donors]. Blood Sci J Iranian Blood Transfus Org Res Cent. 2008;4(Sup 5):331-336
45. Mahdaviani F, Saremi S, Rafiee M. [Prevalence of hepatitis B, C and HIV infection in thalassemic and hemophilic patients of Markazi province in 2004]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2008;4(5):313-322
46. Mansour-Ghanaei F, Fallah MS, Ja'farshad R, Joukar F, Salari A, Tavafzadeh R. Prevalence of hepatitis B surface antigen and hepatitis C virus antibody and their risk factors among Guilan's volunteer blood donors (1998-2003). Hepat Mon. 2007;7(4):239-241
47. Torabi SE, Abed-Ashtiani K, Dehkhoda R, et al. [Prevalence of hepatitis B, C and HIV in hemophiliac patients of East Azarbaijan in 2004]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(Sup 7):291-299
48. Hasanpour SE, Arasteh E, Ghorbani S, Mahdavi S. [Prevalence of Hepatitis B, Hepatitis C and HIV infection in 15 year and older patients admitted in hand surgery emergency]. J Kordestan Univ Med Sci. 2003;8(1):25-33.
49. Vahdani P, Hosseini-Moghaddam SMM, Gachkar L, Sharafi K. Prevalence of hepatitis B, hepatitis C, human immunodeficiency virus, and syphilis among street children residing in southern Tehran, Iran. Arch Iran Med. 2006;9(2):153-155
50. Faranoush M, Ghorbani R, Amin-Bidokhti ME, Vosoogh P, Malek M, Yazdiha MS. [Prevalence of Hepatitis C resulted from blood transfusion in major Thalassemia patients in Semnan, Damghan and Garmsar, 2002]. J Hormozgan Univ Med Sci. 2006;1(10):82-177
51. Hajia M, Shahrokhi N, Amirzargar AA, et al. Prevalence of hepatitis C virus among out-patients of a private laboratory in Tehran. Iranian J Publ Health. 2007;36(1):79-84.
52. Samimi-Rad K, Shahbaz B, Noroozi M, Mahmoodi M, Fayyaz-Vaseghi M. [Prevalence of hepatitis C virus antibody and related risk factors among hemodialysis patients in Markazi province (2004)]. Rahavard-E Danesh , J Arak Univ Med Sci. 2006;9(1):23-33.
53. Moula K, Hajiani E. Prevalence of hepatitis C virus infection in patients with systemic lupus erythematosus: A case-control study. Hepat Mon. 2008;8(1):41-44 (Pubitemid 351802696)
54. Rezazadeh M, Mani-Kashani K, Mohammadi A, et al. Prevalence of human immunodeficiency, hepatitis B and hepatitis C viruses in the first time, repeat and regular donors in blood transfusion center, Hamadan, 2004-2005. Iran J Infect Dis Trop Med. 2006;11(33):55-60.
55. Kasraian L, Torabjahromi SA. [Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2007;5(3):373-378
56. Kamangar E, Atapour M, Sanei-Moghadam E, Zohour AR, Nayeb-Aghaei SM. [Prevalence of serologic markers of Hepatitis B and C and risk factors among dentists and physicians in Kerman, Iran]. J Kerman Univ Med Sci. 2003;4(10):245-250
57. Einollahi B, Hajarizadeh B, Bakhtiari S, et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003;18(7):836-840 (Pubitemid 36936577)
58. Bozorghi SH, Ramezani H, Vahid T, et al. [The prevalence and risk factors of hepatitis C virus infection among thalassemic patients of Qazvin (2005)]. J Qazvin Univ Med Sci. 2008;11(4):54-59
59. Mohammad-Alizadeh AH, Ranjbar M, Seyfoleslami SAR. The frequency of hepatitis C in dialyse patients in Hamadan Ekbatan hospital. Iran J Infect Dis Trop Med. 2002;7(19):27-34.
60. Alavian SM, Hatami S. [Etiology and Risk factors of Acute Viral Hepatitis in Adult Patients reffered to Tehran Hepatitis Center from 2000-2001]. Govaresh. 2001;125(6):125-130
61. Salehi AA, Sharifi M, Norooz-Nejad M, Vazirian Sh. [Seroepidemiology of HIV, HBV & HCV infections in laboratory staff, Kermanshah, 2002]. Behbood, J Kermanshah Univ Med Sci. 2004;19(7):54-149
62. Moniri R, Mosayyebi Z, Moosavi GA. Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors. Iranian J Publ Health. 2004;33(4):38-42.
63. Nassiri-Toosi M, Larti F, Rasteh M, et al. Risk factors and seroprevalence of hepatitis B and C infections among hemodialysis patients in Tehran. Iran J Patho. 2007;2(4):181-186
64. Tamaddoni A, Mohammadzadeh I, Zia'i O. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol. 2007;6(1):41. (Pubitemid 46354208)
65. Saffar MJ, Jooyan AR, Mahdavi MR, Khalilian AR. Seroprevalence of hepatitis A, B, and C and hepatitis B vaccination status among health care workers in Sari-Iran, 2003. J Mazandaran Uni Med Sci. 2005;15(47):67-77.
66. Ghafoorian-Broujerdnia M, Assarehzadegan MA, Zandian Kh. Seroprevalence of Hepatitis B, Hepatitis C and human immunodeficiency virus (HIV) among Thalassemia patients refer to Ahwaz Shapha Hospital, 1999-2004. Scientific Medical Journal. 2006;5(2):528-537
67. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. Journal of Paediatrics and Child Health. 2001;37(6):564-566 (Pubitemid 34042952)
68. Mohtasham-Amiri Z, Ja'fari-Shakib A, Toorchi-Roodsari M. Seroprevalence of hepatitis C and risk factors in hemodialysis patients in Guilan province, Iran. Payesh. 2003;2(4):291-295
69. Behnaz MA, Behnaz F, Mohammadzadeh M. [The prevalence of hepatitis C infection among the dentists of Yazd and assessment of their knowledge about hepatitis]. J Dent. 2004;17(1):55-59
70. Hadadi A, Afhami S, Karbakhsh M, et al. [Epidemiological determinants of occupational exposure to HIV, HBV and HCV in health care workers]. Tehran Univ Med J. 2007;65(9):59-66.
71. Hariri MM, Akbari N, Yavari FM, Javadi E, Javer SH. [Prevalence of Hepatitis B, C and HIV markers in Thalassemic and Hemophilic patients in Isfahan, 2004]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(3):201-204
72. Javadi AA, Poorahmad M, Ata'i B. [The relationship between frequency and duration of imprisonment and the prevalence of HBsAg, AntiHCV and HIV antibody seropositivity in Iranian prisoners]. J Iran Med Council. 2006;24(4):358-364
73. Pourshams A, Malekzadeh R, Akbari MR, Mer'at S. Prevalence and causes of elevated ALT levels among Iranian healthy blood donors. Gastroenterology. 2004;126(4):A307.
74. Javadzadeh-Shahshahani H, Attar M, Yavari M, T., Savabieh Sh. [Study of the prevalence of Hepatitis B, C and HIV infection in Hemophilia and Thalassemia population of Yazd in 2003]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):315-322
75. Shamsian B, Arzanian MT, Shamshiri AR, Alavi S, Khojasteh O. [Blood transfusion status in beta major thalassemia patients in Mofid Children Hospital in Tehran]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2008;4(4):253-258
76. Zali MR, Aghazadeh R, Nouroozi A, Amirrasooli H. Anti-HCV antibody among Iranian IV drug users: Is it a serious problem? Arch Iran Med. 2001;4(3):115-119
77. Zahedi MJ, Zand V, Tavakoli M, Hajariazdeh B, Alavian SM. [The prevalence of hepatitis B and C among thalassemia major patients in Kerman, Iran, and the role of transfusion in infection acqusition]. Govaresh. 2003;8(44):72-78
78. Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19(3):475-478
79. Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis. 2005;5(1):36. (Pubitemid 41363790)
80. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J. 2007;13:98-102. (Pubitemid 47243846)
81. Tanomand A, Montazam H, Kafshnochi M. Seroepidemiology of hepatitis C antibody between rural and urban people: A retrospective study in June to December of 2005 in Malekan City, Iran. Res J Biol Sci. 2007;2(5):561-563
82. Talaie H, Shadnia SH, Okazi A, Pajouhmand A, Hasanian H, Arianpoor H. The prevalence of hepatitis B, hepatitis C and HIV infections in non-IV drug opioid poisoned patients in Tehran-Iran. Pakistan J Biol Sci. 2007;10(2):220-224 (Pubitemid 46197768)
83. Somi M, H., Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus Genotypes in patients with End-Stage Renal Disease in East-Azarbaijan, Iran. Saudi J Kidney Dis Transpl. 2008;19(3):461-465
84. Sharifi-Mood B, Sanei-Moghaddam S, Salehi M, Eshghi P, Khosravi S, Khalili M. Viral infection among patients with hemophilia in the Southeast of Iran. J Med Sci. 2006;6(2):225-228
85. Sharifi-Mood B, Metanat M. Co-infection HIV/AIDs and Hepatitis C. Intern J Virol. 2006;2:63-66
86. Sharifi-Mood B, Metanat M. Infection among hospitalized injection drug users. J Med Sci. 2006;6(4):686-689 (Pubitemid 44613193)
87. Sharifi-Mood B, Khosravi S. Tattooing: A major source for viral infection. J Med Sci. 2006;6(4):678-680 (Pubitemid 44613191)
88. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007;28(10):1516-1519 (Pubitemid 350065136)
89. Shariatzadeh SMA, Nadderi GhA. [Study of HBV, HIV and HCV infection in major Thalassemic patients in Central province of Iran]. J Uromia Univ Med Sci. 2000;1(11):28-30
90. Abdollah-Shamshirsaz A, Kamgar M, Bekheirnia M, et al. The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: A multicenter prospective interventional study. BMC nephrology. 2004;5(13).
91. Seyrafian S, Mobasherizadeh S, Javadi A, Akhzari M, Esfandiari J. Comparison and prevalence of hepatitis B and C infection and hepatitis B vaccination in hemodialysis patients and staffs in 13 hemodialysis centers in Isfahan (Iran). Nephrol Dial Transpl. 2006;21((Suppl 4)):iv 484.
92. Semnani S, Roshandel GR, Abdolahi N, et al. HBV/HCV co-infection in Iran: A seroepidemiological based study. Pakistan J Biol Sci. 2006;9(13):2538-2540 (Pubitemid 44861338)
93. Sayad B, Shamseddin-Saeed F, Keyvani H, et al. Seroepidemiology of hepatitis C in Kermanshah (West of Iran, 2006). Hepat Mon. 2008;8(2):141-146 (Pubitemid 351936058)
94. Sane'i-Moghaddam E, Khosravi S, Gharibi T. Prevalence of HBsAg and Anti-HCV reactivity in donors embarking on direct blood donation and among first-time blood donors in Zahedan Blood Transfusion Center [In Persian]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;1(2):19-25.
95. Sana'izadeh H, Taghaddosinejad F, Amo'i M, Bayatmakoo K, Fahim P. Autopsies on bodies without antemortem risk factors for HCV, HBV and HIV infections: Are they safe? Pathology. 2002;34(6):582-583
96. Sana'izadeh H. Seroprevalence of HIV, HBV and HCV in forensic autopsies, which have been presumed to be low risk, in Tehran, the Capital of Iran. Internet J Pathol. 2002;2(1).
97. Salehi M, Sharifi B. Acute viral hepatitis in Zahedan: A serological analyzes of 263 case. J Med Sci. 2005;5(2):101-105
98. Salehi M, Sane'i-Moghaddam E, Bozorgzadeh SR, Haghighi MR. [Seroepidemiology of hepatitis C in Sistan and Baloochestan province.] Tabibe Shargh Res J. 2001;3(3):165-168
99. Salehi M, Sanei-Moghaddam E, Ansari-Moghaddam AR. [HBsAg and Hepatitis C infection prevalence in prisoners of Sistan and Baloochestan province]. Tabibe Shargh Res J. 2001;3(4):203-206
100. Salehi M, Sanei ME, Khosravi S. [Etiology of acute viral Hepatitis in Zahedan]. Research in Medicine, J Shahid Beheshti Sch Med. 2003;4(26):245-248
101. Sadegi-Bazargani H, Arshi S, Mortazazadeh AA, et al. [Health status among migrant tribes (Ashayer) of Ardabil province]. J Ardabil Univ Med Sci. 2005;5(2):150-155
102. Sadeghi A. [Prevalence of Hepatitis B and C in blood donors in East Azarbaijan province]. J Uromia Univ Med Sci. 1998;9(4):242.
103. Sabayan B, Mo'tamedifar M, Zamiri N, Karamifar K, Chohedry A. Viral infections, prevalence and costs: A 5-year, hospital based, retrospective observational study in Shiraz, Iran. Pak J Med Sci. 2007;23(4):580-584
104. Rezvan H, Moosavi-Jahed Z. Prevalence etiology of acute viral hepatitis in hospitalized patient at infectious ward of 5 major teaching hospitals, Tehran. Iran J Infect Dis Trop Med. 2003;8(21):40-43
105. Rahbar AR, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Pol. 2004;15(2):151-155 (Pubitemid 38373954)
106. Pourshams A, Malekzadeh R, Monavvari A, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol. 2005;20(2):229-233 (Pubitemid 40347316)
107. Poormand GR, Poormand MR, Salem S, et al. [Posttransplantation infectious complications in Iranian kidney recipients: A prospective study of 142 patients]. J Sch Public Health & Health Res Inst. 2006;4(2):59-71.
108. Pourazar A, Abkbari N, Hariri M, Yavari F, Akbari Sh. [Evaluation of demographic profiles and prevalence of major viral markers in first time vs repeat blood donors in Isfahan]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):323-329
109. Mahmoodian-Shooshtari M, Poorfathollah AA. An overview analysis of blood donation in the Islamic Republic of Iran. Arch Iran Med. 2006;9(3):200-203 (Pubitemid 44122226)
110. Nour-Kojory S, Alaoddowleie H, Seddighian F. [Efficacy of confidential self-exclusion and failed systems on blood donation safety in Sari and Behshahr blood donors]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2007;4(2):153-158
111. Nobakht-Haghighi A, Zali M, R,, Nouroozi A. Hepatitis C antibody and related risk factors in hemodialysis patients in Iran. J Am Soc Nephrology. 2001;12:233A.
112. Mojtabavi-Na'ini M, Derakhshan F, Hoorfar H, Derakhshan F, Makarian-Rajab F. Analysis of the related factors in hepatitis C virus infection among hemophilic patients in Isfahan, Iran. Hepat Mon. 2007;7(2):59-62.
113. Moradi A, Mohagheghi AH, Shahraki S, et al. Seroepidemiology of rubella, measles, HBV, HCV and B19 virus within women in child bearing ages (Saravan City of Sistan and Bloochastan Province). Res J Microbiol. 2007;2(3):289-293 (Pubitemid 46955813)
114. Mirnaseri SMM, Poostchi H, Nasseri-Moghaddam S, et al. [HCV in intravenous drug users]. Govaresh. 2005;10(2):80-86
115. Mirmomen S, Alavian SM, Hajarizadeh B, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9:319-323 (Pubitemid 44803571)
116. Mirahmadizadeh AR, Kadivar MR, Hemmati AR, Javadi A. Infection with HIV and hepatitis C and B viruses among injecting drug users in Shiraz, Southern Iran. 15th Int Conf AIDS; 2004 2004 Jul 11-16; Bangkok, Thailand.; 2004.
117. Masaeli Z, Jaberi M, R,, Magsoudlou M. [A comparison of seroprevalence of blood-borne infections among regular, sporadic and first-time blood donors in Isfahan]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):301-307
118. Mardani A, Hosseini S, Kheirkhahi N. [Study of confidential self-exclusion cases in Qom Regional Blood Transfusion Center]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;3(2):183-189
119. Mansour-Ghanaei F, Forootan H, Fallah MS, et al. [Hepatitis viruses seromarkers and liver function in Guilan hemophilia]. J Guilan Univ Med Sci. 2002;10(39-40):56-64.
120. Makhloogh A, Mahdavi MR, Haghshenas M, Ghasemian R, Jamshidi M. Hepatitis C prevalence in hemodialysis patients in Mazandaran, Iran: A survey by polymerase chain reaction and serological methods. Res J Biol Sci. 2008;3(2):265-268
121. Mahdaviani F, Saremi S, Maghsoodloo M, Poorfathollah AA. [Prevalence of blood transmitted viral infections in regular and non-regular donors of Arak Blood Center]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(Sup 7):343-351
122. Khodadadizadeh A, Esmaeili-Nadimi A, Hosseini SH, Shabani-Shahrbabaki Z. [The Prevalence of HIV, HBV and HCV in Narcotic addicted Persons Referred to the out Patient Clinic of Rafsanjan University of Medical Sciences in 2003]. J Rafsanjan Univ Med Sci. 2006;1(5):23-30.
123. Kheradpezhouh M, Taremi M, Gachkar L, Aghabozorgi S, Khoshbaten M. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis. J Microbiol Immunol Infect. 2007;40(2):106-111 (Pubitemid 46999316)
124. Khedmat H, Fallahian F, Abolghasemi H, et al. Seroepidemiologic Study of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus and Syphilis Infections in Iranian Blood Donors. Pak J BioI Sci. 2007;10(24):4461-4466 (Pubitemid 350305614)
125. Khadem-Ansari MH, Omrani M. Evaluation of diagnostic value of ELISA method (EIA) & PCR in diagnosis of hepatitis C virus in hemodialysis patients. Hepat Mon. 2006;6(1):19-23.
126. Kasraian L, Torab-Jahromi A, Farahangiz B. A survey of epidemiological status of hepatitis C infection among Shirazian blood donors in 2005. J Clin Virol. 2006;36:S214.
127. Kasraian L, Torab-Jahromi A, Farahangiz B. Trends in incidence of major transfusion transmissible viral infection in Fars blood donors from 2002 till end of 2006. Vox Sanguinis. 2006;91:39-40.
128. Kashef S, Karimi M, Amirghofran Z, et al. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int J Lab Hematol. 2008;30(1):11-16
129. Karimi A. Seroprevalence of HBV, HCV and HIV among intravenous drug users in Iran. J Clin Virol. 2006;36:S210-1.
130. Kadivar MR, Mirahmadizadeh MR, Karimi A, Hemmati A. The prevalence of hepatitis C and Human Immunodeficiency Virus antibodies in thalassemic patients in Shiraz. Med J Iran Hosp. 2001;4(1):18-21.
131. Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iranian J Publ Health. 2006;35(4):33-36 (Pubitemid 46178736)
132. Jahangirnejad M, Makvandi M, Kelishadi M, Eizadikha V. Study on hepatitis C virus infection among the dental students. Biochem Cell Arch. 2006;6(1):65-69
133. Jadali Z, Eslami MB, San'ati MH, et al. Hepatitis C virus antibodies and Vitiligo disease. Iranian J Publ Health. 2005;34(1):23-26
134. Mohtasham-Amiri Z. Prevalence of hepatitis C virus infection and risk factors in an incarcerated population in Iran. J Thromb Haemost. 2003;1:1.
135. Imani R, Karimi A, Kasaeian N. [The relevance of related-risk behaviors and seroprevalence of HBV, HCV and HIV infection in intravenous drug users from Shahrekord, Iran, 2004]. J Shahrekord Univ Med Sci. 2006;1(8):58-62.
136. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran - a multicenter study. J Med Virol. 2006;78(5):569-573
137. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol. 2006;12(30):4884-4887 (Pubitemid 44323217)
138. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. . World J Gastroenterol. 2006;12(43):7025-7028 (Pubitemid 44834895)
139. Ghaderi AA, Makhmalbaf Z. The relationship between lichen planus and hepatitis C in Birjand, Iran. Shiraz E-Medical Journal. 2007;8(2):72-79
140. Ganji A, Safavi M, Noura'i M, et al. [Digestive and liver diseases statistics in several referral centers in Tehran, 2000-2004]. Govaresh. 2006;11(1):33-38
141. Farzaneh S, Reza SM, Reza SH. Molecular characteristic and epidemiology of hepatitis B, C viruses in the Shiraz Province of Iran. J Clin Virol. 2006;36:S36.
142. Esma'ili MR, Mostafazadeh A, Sharbatdaran M, Hajiahmadi M, Alijanpoor M. Hepatitis C in blood products receivers due to acute illness before screening program. Pediatr Res. 2005;58(2):373.
143. Esma'ili H, Hamidiya Z, Mirlatifi S, et al. Seroprevalence of blood-borne infections among blood donors in Boushehr, Iran. Int J Antimicrob Ag. 2007;29:S337.
144. Mansour-Ghanaei F, Fallah MS, Shafaghi A, et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Med Sci Monit 2002;8:797-800.
145. Cohan N, Zandeh T, Samiei SH, Ataie Z, Kavari M. The prevalence and clinical significance of hepatitis B and C coinfection. Iran J Med Sci. 2006;31(3):156-158 (Pubitemid 44510660)
146. Broumand B, Abdollah-Shamshirsaz AR, Kamgar M, et al. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in Tehran: Preliminary report from "the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients" project. Saudi J Kidney Dis Transpl. 2002;13(4):467-472
147. Broumand B, Kamgar M, Bekheirnia M, et al. Incidence of hepatitis C virus infection and its risk factors among hemodialysis patients in Tehran: A multicenter study. J Am Soc Nephrol. 2003;14:852A.
148. Bozorghi SH, Ahmadzad-Asl M, Ramezani H, Kargarfard H, Alavian SM. [Study of Viral Infections Prevalence in Blood Donors of Qazvin Province in Different Time Intervals and During Bam Earthquake]. Govaresh. 2007;4(11):242-248
149. Khodabakhshi B, Abbasi A, Fada'i F, Rabi'i MR. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Gorgan prisoners. J Med Sci. 2007;7(2):252-254
150. Attarchi Z, Ghafouri M, Hajibeigi B, Assari Sh, [Alavian SM. Donor deferral and blood-borne infections in blood donors of Tehran]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;7(2):353-364
151. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, Southwest Iran. Int J Infect Dis. 2008;12(4):387-390
152. Asadi S, Marjani M. [Epidemiology and prevalence of infectious diseases in IVDA in Infectious Wards of Shahid Beheshti University of Medical Sciences, 1381-82]. Iran J Infect Dis Trop Med. 2004;25(9):53-61.
153. Ansari A, Tabatabai SH. [Study of factors in major beta thalassemia complications in patients admitted to Shahid Dastghaib hospital in Shiraz, Iran (2004-5)]. J Sabzevar Med Sci. 2007;14(1):62-72.
154. Ansari H, Kamani H, Arbabi-Sarjo A. Prevalence of hepatitis C and related factors among beta-thalassemia major patients in Southern Iran in 2005-2006. J Med Sci. 2007;7(6):997-1002.
155. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepatitis. 2002;9(5):390-392 (Pubitemid 35056592)
156. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J. 2007;13(2):250-256 (Pubitemid 47045989)
157. Aminzadeh Z, Aghazadeh-Sarhangipoor K. Seroepidemiology of HIV, syphilis, hepatitis B and C in intravenous drug users at Loghman Hakim hospital. Iran J Med Microbiol. 2007;1(3):53-56
158. Amini S, Mahmoodabadi SA, Lamian S, Joola'i M, Mahmoodi-Farahani M.
159. Mohammad-Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan - Iran. World J Gastroenterol. 2005;11(26):4085-4089 (Pubitemid 41235607)
160. Alavi-Na'ini R, Sharifi-Mood B, Metanat M, et al. Risk factors of hepatitis C infection among household contacts in Zahedan. J of Mil Med. 2006;7(4):343-348
161. Alavian SM, Rajai M, Arab MS, et al. Viral Hepatitis in Iranian Armed Forces: Prevalence of HBV and HCV in the Wounded-In-Action (WIA). Hepat Mon. 2005;4(5):129-131
162. Alavian SM, Kafaee J, Yektaparast B, Hajarizadeh B, Doroudi T. The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. Transfusion Today. 2002;53:3-4.
163. Alavi SM, E'temadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co-infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci. 2007;23(4):510-513
164. Mirmomen SH, Ghofrani H, Ebrahimi Daryani N, Niknami H. [Frequency and clinical importance of hepatitis C in thalassemic patients]. Govaresh. 2001;6(33-34):120-124
165. Merat S, Sohrabpoor AA, Khaleghi S, et al. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C and inherited bleeding disorders. Hepat Mon. 2004;4(7):59-64.
166. Naghavi N, Samimirad K, Salehi M, Shanesazzadeh M, H. Hoorfar, Nategh R. Study of hepatitis C frequency with the method of RT-PCR in thalassemic and hemophiliac patients of Isfahan province, 2005. Iran J Infect Dis Trop Med. 2007;11(35):33-39
167. Mohammad-Alizadeh AH, Rezazadeh M, Ranjbar M, et al. [Frequency of hepatitis B and C and their relation with factor VIII inhibitor in hemophiliac patients of Hamedan province, 2004]. Research in Medicine, J Shahid Beheshti Sch Med. 2006;30(2):119-123
168. Gachkar L, Taremi M, Khoshbaten M, et al. [Frequency of antibodies to hepatitis E virus among male blood donors in Tabriz]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;2(5):157-162
169. Kompani F, Rezayi N. [Study of hepatitis C prevalence and its association with glucose tolerance disorder and diabetes mellitus in patients with beta-thalassemia major]. J Kordestan Univ Med Sci. 2008;12:45-52.
170. Kazeminejad V, Azarhoosh R, Moulana AA, Dehbashi GR. [Frequency of hepatitis B, C and HIV in blood donors and patients referring to Gorgan Blood Transfusion Organization (2003)]. J Gorgan Univ Med Sci. 2005;7(1):84-86
171. Kazerani H. [Epidemiologic study of HCV, HBV and HIV positive in surgery-undergone patients and cardiac invasions in Imam Ali hospital in Kermanshah]. J Kordestan Univ Med Sci. 2007;11:42-47
172. Alavian SM, Einollahi B, Hajariazdeh B, Bakhtiari S, Nafar M, Ahrabi S. [Prevalence and risk factors of hepatitis C in hemodialysis patients]. Pajoohandeh. 2003;8(5):315-319
173. Alavian SM, Manzoori-Joybari H, Asari SH, Moghani Lankarani M. [Is a war injury history a risk factor for HDV infection?]. J Mil Med. 2005;7(2):95-99
174. Alavian SM, Rajai M, Saeedi-Arab M, et al. [Prevalence of HBV and HCV in disabled patients of " 27 Hazrate Rasool" corps and ground force of Guardians of the Islamic Revolution Army] . J Mil Med. 2002;4(1):7-10.
175. Alavian S, M,, Kafaei J, Yektaparast B, et al. [The prevalence of Hepatitis B and C among Thalassemia major patients in Qazvin]. Kowsar Med J. 2002;4(7):325-419
176. Abdi J, Mo'azzami-Goodarzi HR. [Prevalence of HBcAb among the HBsAg negative first-time blood donors in Khorramabad and Borujerd blood centers]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2008;4(5):323-329
177. Taheri-Azbarmi Zn, Noori Sn, Joukar F, et al. [Transfusion transmitted diseases in Rasht blood donors]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2008;4(5):337-343
178. Sharifi-Mood B, Metanat M, Ghaedi HR. [Frequency of blood born viruses transmission in the people with tatoo in Zahedan (2004-2006)]. Iran J Infect Dis Trop Med. 2007;12(37):67-69
179. Salman-Roghani H. [Study of HCVAb, HBCAb and HBSAb frequency in volunteers of seronegative blood donation for HBS-Ag]. J Yazd Univ Med Sci. 2005;12(4):10-16
180. Zakizadeh M, Sadeghian A, Bagheri-Nesami M, et al. [Seroprevalence and risk factors of hepatitis C in addicted prisoners of Khazarabad prison in Sari]. J Yazd Univ Med Sci. 2006;14(2):29-37.
181. Razavioon T. [Prevalence of hepatitis B and C and HIV I & II infections in Fereidoonkenar and Babolsar regions]. Laboratory News. 2006;35:18.
182. Rostami-Jalilian M, Omidgha'emi M, Kasa'ian N. [Study of hepatitis B and C relation with deep venous thrombosis (DVT) in injection drug users]. J Mil Med. 2006;8(1):78-81.
183. Dadgaran SA. [Prevalence and risk factors of hepatitis C virus among hemodialysis patients]. J Guilan Univ Med Sci. 2005;55:76-86.
184. Habibzadeh Sh, Davarnia B, Bazaz Ataei A, Bagherzadeh S, Hamidkholgh GhR. [Epidemiological evaluation of transfusion transmitted diseases in Ardabil in Tasoua and Ashoura (2003)]. Blood, Sci J Iranian Blood Transfus Org Res Centr. 2005;1(2):55-60.
185. Chamani L, Zera'ati H, Asgari S, Shabestari O, Soltan-Ghorayi H, Habibzadeh-Shoja'i A. Seroepidemiologic study of CMV, toxoplasma and hepatitis B and C in clients of Avicenna Infertility Clinic. Iran J Infect Dis Trop Med. 2007;11(35):59-63.
186. Amini Kafi-Abad S, Talebian A, Ranjbar F, Moghtadayi M, Sobhani M, Sami'i S. [Screening of donated blood for hepatitis C infection in Iranian blood donors: A preliminary study]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2005;2(3):13-22.
187. Amirzargar AA, Shahrokhi N, Hajia M, Farzanekhah M. Study of HCV positive patients and identified genotypes frequency in 2003-2004 with PCR. Lab Diag. 2005;41:5-8.
188. Emam-Ghoreyshi F, Fathi GA, Mohtashami A. [Evaluation of demographic characteristics and hepatitis B, C and HIV prevalence among blood donors in Jahrom]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):373-378
189. Aghajanipoor K, Zandieh T. [Seroepidemiological investigation of Hepatitis B, C and HIV virus in safe blood donors of Babol Blood Transfusion Center]. Blood, Sci J Iranian Blood Transfus Org Res Cent. 2006;2(7):339-341
190. Afzali H, Taghavi-Ardakani A, Vali G, R. [Seroepidemiology of Hepatitis B and C in blood donors in Kashan, 1996-2001]. Feyz, J Kashan Univ Med Sci. 2002;23:43-51.
191. Azarkar Z, Sharifzadeh G, Miraki MA. [Prevalence of Hepatitis B and C and HIV in prisonned people in Birjand]. J Birjand Univ Med Sci. 2007;14(2):50-56
192. Alavian SM, Hajariazdeh B, Doroodi T, et al. [Study of hepatitis B and C prevalence in thalassemic major patients of Qazvin province]. Kowsar Med J. 2003;7(4):319-325
193. Ameen R, Sanad N, Al-Shemmari S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005;45(12):1973-1980 (Pubitemid 43971426)
194. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J. 2002;23(11):1356-1360 (Pubitemid 36113491)
195. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13(1):9-19.
196. Sandesh K, Varghese T, Harikumar R, et al. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala. Trop Gastroenterol. 2006;27(2):80-83
197. Erden S, Buyukozturk S, Calangu S, Yilmaz G, Palanduz S, Badur S. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract. 2003;12(3):184-188 (Pubitemid 36667651)
198. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer. 2009;124(3):690-697
199. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122(10):990-1003.
200. Stvilia K, Tsertsvadze T, Sharvadze L, et al. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia. J Urban Health. 2006;83(2):289-298 (Pubitemid 44341580)
201. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714
202. Galetskii SA, Seniuta NB, Syrtsev AV, et al. [Analysis of some viral infections, transmitted by parenteral and sexual routes, in the Republic of Azerbaijan]. Vopr Virusol. 1999;44(5):232-236
203. Brito VO, Parra D, Facchini R, Buchalla CM. [HIV infection, hepatitis B and C and syphilis in homeless people, in the city of Sao Paulo, Brazil]. Rev Saude Publica. 2007;41 Suppl 2:47-56.
204. Mateu-Gelabert P, Treloar C, Calatayud VA, et al. How can hepatitis C be prevented in the long term? Int J Drug Policy. 2007;18(5):338-340 (Pubitemid 47374509)
205. Alavian SM. We Need a New National Approach to Control Hepatitis C: It is Becoming too Late. Hepat Mon. 2008;8(3):1-3.
206. Dodd RY, Notari EPt, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42(8):975-979
207. Chiavetta JA, Escobar M, Newman A, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. Can Med Assoc J. 2003;169(8):767-773
208. Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill. 2005;10(2):8-11.
209. Velati C, Fomiatti L, Baruffi L, Romano L, Zanetti A. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003). Euro Surveill. 2005;10(2):12-14
210. Gonzalez M, Regine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Transfusion. 2005;45(10):1670-1675
211. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006;45(4):607-616 (Pubitemid 44316867)
212. Liu P, Shi ZX, Zhang YC, Xu ZC, Shu HS, Zhang XY. A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus. Transfusion. 1997;37(7):732-736 (Pubitemid 27297614)
213. Mujeeb SA, Hafiz A. Low-cost screening of blood for HCV infection in the developing world. Vox Sang. 1998;74(3):210.
214. Thakral B, Marwaha N, Chawla YK, et al. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006;124(4):431-438 (Pubitemid 46592124)
215. Candotti D, Sarkodie F, Allain JP. Residual risk of transfusion in Ghana. Br J Haematol. 2001;113(1):37-39
216. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet. 1992;340(8816):427.
217. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: A review. Transfus Med. 2007;17(6):425-433 (Pubitemid 350198296)
218. Silva LK, Silva MB, Rodart IF, et al. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res. 2006;39(5):595-602. (Pubitemid 43676608)
219. Barril G, Traver JA. Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antivir Res. 2003;60(2):129-134 (Pubitemid 37452457)
220. Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol. 2009;15(6):641-646
221. Dentico P, Buongiorno R, Volpe A, et al. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol. 1992;38(1):49-52.
222. Alavian SM, Tabatabaei SV. RE: Serum viral markers in Iranian patients with congenital bleeding disorder. Ann Saudi Med. 2009;29(4):322.
223. Alavian SM. Triangular Clinics: The Way of The Future. Hepat Mon. 2005;5(3):51-.